Hematopoietic Stem Cell Transplantation
-
Subject Areas on Research
-
A Multicenter Consortium to Define the Epidemiology and Outcomes of Inpatient Respiratory Viral Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients.
-
A Multicenter Retrospective Analysis Stressing the Importance of Long-Term Follow-Up after Hematopoietic Cell Transplantation for β-Thalassemia.
-
A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.
-
A comparative study of the generation of dendritic cells from mobilized peripheral blood progenitor cells of patients undergoing high-dose chemotherapy.
-
A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution.
-
A critical role for the autophagy gene Atg5 in T cell survival and proliferation.
-
A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
-
A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma.
-
A novel approach for quantification of KIR expression in healthy donors and pediatric recipients of hematopoietic SCTs.
-
A novel approach for the analysis of T-cell reconstitution by using a T-cell receptor beta-based oligonucleotide microarray in hematopoietic stem cell transplantation.
-
A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis.
-
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.
-
A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up.
-
A phase II study of elacytarabine in combination with idarubicin and of human equilibrative nucleoside transporter 1 expression in patients with acute myeloid leukemia and persistent blasts after the first induction course.
-
A pilot study comparing the neutropenic diet to a non-neutropenic diet in the allogeneic hematopoietic stem cell transplantation population.
-
A predictive model for relapse in high-risk primary breast cancer patients treated with high-dose chemotherapy and autologous stem-cell transplant.
-
A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation.
-
A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results.
-
A randomized phase II trial of fludarabine/melphalan 100 versus fludarabine/melphalan 140 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma.
-
A randomized trial of amifostine and carmustine-containing chemotherapy to assess lung-protective effects.
-
A randomized trial of recombinant human interleukin-11 following autologous bone marrow transplantation with peripheral blood progenitor cell support in patients with breast cancer.
-
A successful unrelated peripheral blood stem cell transplantation with reduced intensity-conditioning regimen in a patient with late-onset purine nucleoside phosphorylase deficiency.
-
ASBMT policy statement regarding the methodology of evidence-based reviews in evaluating the role of blood and marrow transplantation in the treatment of selected diseases. American Society for Blood and Marrow Transplantation.
-
Aberrant B-cell homeostasis in chronic GVHD.
-
Acute graft-versus-host disease: are we close to bringing the bench to the bedside?
-
Acute graft-vs-host disease: pathobiology and management.
-
Acute myeloid leukemia clinical practice guidelines in oncology.
-
Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantation.
-
Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation.
-
Advances in pediatric hematopoietic stem cell transplantation.
-
Aerosolized ribavirin: the most expensive drug for pneumonia.
-
Alemtuzumab for the prevention and treatment of graft-versus-host disease.
-
Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.
-
Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research Analysis.
-
Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art.
-
Allogeneic Stem-Cell Transplantation - A T-Cell Balancing ACT.
-
Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients.
-
Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.
-
Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs.
-
Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
-
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.
-
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease.
-
Allogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease.
-
Allotransplantation for patients age ≥40 years with non-Hodgkin lymphoma: encouraging progression-free survival.
-
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
-
Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR.
-
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.
-
American Pediatric Society's 2014 John Howland Award acceptance lecture: saving lives through early diagnosis.
-
Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.
-
An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.
-
An effective strategy for decontamination, ex vivo expansion, and storage of human fetal liver hematopoietic stem cells.
-
An unconditioned bone marrow transplantation in a child with purine nucleoside phosphorylase deficiency and its unique complication.
-
Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry.
-
Antibodies to stem cell marker antigens reduce engraftment of hematopoietic stem cells.
-
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.
-
Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation.
-
Autologous Stem-Cell Transplantation for Severe Scleroderma.
-
Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis.
-
Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research.
-
Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement.
-
Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.
-
Autologous serum eye drops for severe dry eye syndrome in a patient with chronic graft-versus-host disease: a case report.
-
Autologous stem cell transplantation for autoimmune diseases: issues in protocol development.
-
Autologous stem cell transplantation for refractory or poor-risk relapsed Hodgkin's lymphoma: effect of the specific high-dose chemotherapy regimen on outcome.
-
Autologous transplantation followed closely by reduced-intensity allogeneic transplantation as consolidative immunotherapy in advanced lymphoma patients: a feasibility study.
-
Autologous transplantation for relapsed non-Hodgkin's lymphoma using intravenous busulfan and cyclophosphamide as conditioning regimen: a single center experience.
-
Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse Survival.
-
B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways.
-
B cells in chronic graft-versus-host disease.
-
B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality.
-
Bacterial and fungal contamination of human fetal liver collected transvaginally for hematopoietic stem cell transplantation.
-
Banking and transplantation of unrelated donor umbilical cord blood: status of the National Heart, Lung, and Blood Institute-sponsored trial.
-
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
-
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation.
-
Body weight and outcome of hematopoietic stem cell transplantation.
-
Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study.
-
Bone marrow metastases.
-
Bone marrow transplantation for sickle cell disease.
-
Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization.
-
Brincidofovir (CMX001) Toxicity Associated With Epithelial Apoptosis and Crypt Drop Out in a Hematopoietic Cell Transplant Patient: Challenges in Distinguishing Drug Toxicity From GVHD.
-
Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial.
-
Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis.
-
CARE-PARTNER: a computerized knowledge-support system for stem-cell post-transplant long-term follow-up on the World-Wide-Web.
-
CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation.
-
CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model.
-
CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire.
-
Can We Cure Light Chain Deposition Disease of the Kidneys?-A Review and Case Report of a Patient Treated With a Triple Transplant Approach.
-
Can we agree on patient-reported outcome measures for assessing hematopoietic cell transplantation patients? A study from the CIBMTR and BMT CTN.
-
Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility?
-
Cardiac Dysfunction and Heart Failure in Hematopoietic Cell Transplantation Survivors: Emerging Paradigms in Pathophysiology, Screening, and Prevention.
-
Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer.
-
Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study.
-
Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study.
-
Cardiovascular Function in Long-Term Hematopoietic Cell Transplantation Survivors.
-
Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.
-
Cell therapy for diverse central nervous system disorders: inherited metabolic diseases and autism.
-
Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful.
-
Challenges and opportunities for international cooperative studies in pediatric hematopoeitic cell transplantation: priorities of the Westhafen Intercontinental Group.
-
Changes in outcomes (1996-2004) for pediatric oncology and hematopoietic stem cell transplant patients requiring invasive mechanical ventilation.
-
Childhood cerebral X-linked adrenoleukodystrophy: diffusion tensor imaging measurements for prediction of clinical outcome after hematopoietic stem cell transplantation.
-
Children Receiving Hematopoietic Stem Cell Transplantation are at Increased Risk of Onychocryptosis Requiring Surgical Management.
-
Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.
-
Chronic kidney disease after hematopoietic cell transplantation: a systematic review.
-
Chronic myelogenous leukemia, version 1.2015.
-
Chronic myelogenous leukemia.
-
Chronic myelogenous leukemia.
-
Chronic myelogenous leukemia.
-
Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.
-
Circulating CD34+ cell counts are predictive of CD34+ peripheral blood progenitor cell yields.
-
Cirrhosis of the liver in long-term marrow transplant survivors.
-
Clinical applications for biomarkers of acute and chronic graft-versus-host disease.
-
Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency.
-
Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.
-
Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI.
-
Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant.
-
Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State.
-
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases.
-
Clinical utility of computed tomography screening of chest, abdomen, and sinuses before hematopoietic stem cell transplantation: the St. Jude experience.
-
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.
-
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies.
-
Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.
-
Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
-
Clonal contributions of small numbers of retrovirally marked hematopoietic stem cells engrafted in unirradiated neonatal W/Wv mice.
-
Cognitive problems following hematopoietic stem cell transplant: relationships with sleep, depression and fatigue.
-
Combination antifungal therapy: what can and should we expect?
-
Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data.
-
Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.
-
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.
-
Comparative cost-effectiveness analysis of voriconazole and fluconazole for prevention of invasive fungal infection in patients receiving allogeneic hematopoietic cell transplants.
-
Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
-
Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.
-
Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.
-
Comparison of seven-day and repeated 24-hour recall of symptoms in the first 100 days after hematopoietic cell transplantation.
-
Complete remission of psoriasis after autologous hematopoietic stem-cell transplantation for multiple myeloma.
-
Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: a longitudinal follow-up of 415 patients.
-
Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility.
-
Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease.
-
Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures.
-
Cord blood banking for potential future transplantation: subject review. American Academy of Pediatrics. Work Group on Cord Blood Banking.
-
Cord blood is the optimal graft source for the treatment of pediatric patients with lysosomal storage diseases: clinical outcomes and future directions.
-
Cord blood stem cells.
-
Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.
-
Cost effectiveness of myeloid growth factors in cancer chemotherapy.
-
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
-
Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders.
-
Cutaneous acquired toxoplasmosis in a child: a case report and review of the literature.
-
Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma.
-
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis.
-
Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial.
-
Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease.
-
Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
-
Diagnosis, Treatment and Long-Term Follow Up of Patients with ADA Deficiency: a Single-Center Experience.
-
Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.
-
Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: a pilot study.
-
Dissemination and commercialization of hematopoietic progenitor cell transplantation.
-
Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34.
-
Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes.
-
Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers.
-
Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature.
-
Dose intensive melphalan and cyclophosphamide with autologous hematopoietic stem cells for recurrent medulloblastoma or germinoma.
-
Dose of prophylactic platelet transfusions and prevention of hemorrhage.
-
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.
-
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time.
-
Early-onset monocyte-B-natural killer-dendritic cells' deficiency successfully treated with hematopoietic stem cell transplantation.
-
Early-stage melanoma and hematopoietic stem cell transplantation outcomes.
-
Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support.
-
Effect of Inpatient Palliative Care During Hematopoietic Stem-Cell Transplant on Psychological Distress 6 Months After Transplant: Results of a Randomized Clinical Trial.
-
Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
-
Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103).
-
Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.
-
Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCT.
-
Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.
-
Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors.
-
Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma.
-
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.
-
Emerging trends in transplantation of inherited metabolic diseases.
-
Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET).
-
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation.
-
Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency.
-
Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction.
-
Enrichment of peripheral blood stem cells in a primate model following administration of a single dose of rh-IL-1 beta.
-
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
-
Ethical issues in umbilical cord blood banking. Working Group on Ethical Issues in Umbilical Cord Blood Banking.
-
Evaluation of pedometry as a patient-centered outcome in patients undergoing hematopoietic cell transplant (HCT): a comparison of pedometry and patient reports of symptoms, health, and quality of life.
-
Evaluation of the effect of age on treatment-related mortality and relapse in patients with high-risk primary breast cancer receiving high-dose chemotherapy.
-
Evaluation of white matter anisotropy in Krabbe disease with diffusion tensor MR imaging: initial experience.
-
Evidence for an immune barrier after in utero hematopoietic-cell transplantation.
-
Ex Vivo Expansion or Manipulation of Stem Cells to Improve Outcome of Umbilical Cord Blood Transplantation.
-
Ex vivo expanded peripheral blood progenitor cells provide rapid neutrophil recovery after high-dose chemotherapy in patients with breast cancer.
-
Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation.
-
Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer.
-
FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.
-
Factors associated with mortality in transplant patients with invasive aspergillosis.
-
Fatal re-expansion pulmonary edema associated with increased lung IL-8 levels following high-dose chemotherapy and autologous stem cell transplant.
-
Fate of patients with newly diagnosed acute myeloid leukemia who fail primary induction therapy.
-
Feasibility of a symptom management intervention for adolescents recovering from a hematopoietic stem cell transplant.
-
Feasibility of frequent patient-reported outcome surveillance in patients undergoing hematopoietic cell transplantation.
-
Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors.
-
Fertility challenges for women with sickle cell disease.
-
Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiency.
-
Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients.
-
Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics.
-
Four-cycle high-dose therapy with hematopoietic support for metastatic breast cancer: no improvement in outcomes compared with single-course high-dose therapy.
-
Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing's sarcoma.
-
Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency.
-
Fungal infection prevention after hematopoietic cell transplantation.
-
Fungal infections in transplant and oncology patients.
-
Galactomannan, β-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
-
Gene therapy for SCID--a complication after remarkable progress.
-
Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.
-
Gene therapy for human SCID: dreams become reality.
-
Gene therapy for immunodeficiency due to adenosine deaminase deficiency.
-
Gene therapy in transplantation.
-
Genotype, phenotype, and outcomes of nine patients with T-B+NK+ SCID.
-
Globoid cell leukodystrophy (Krabbe disease): normal umbilical cord blood galactocerebrosidase activity and polymorphic mutations.
-
Graft hyporeactivity induced by donor-derived dendritic cell progenitors.
-
Graft--versus--breast cancer effect by allogeneic hematopoietic stem-cell transplantation: a possible new frontier.
-
Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia.
-
Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.
-
Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
-
Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation.
-
Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency.
-
Haploidentical hematopoietic cell transplantation.
-
Haploidentical transplantation for leukemia.
-
Health-Related Quality of Life among Children and Adolescents during Hematopoietic Stem Cell Transplant Recovery.
-
Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia.
-
Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma.
-
Hematopoietic Stem Cell Transplantation Activity in Pediatric Cancer between 2008 and 2014 in the United States: A Center for International Blood and Marrow Transplant Research Report.
-
Hematopoietic Stem Cell Transplantation for CD40 Ligand Deficiency: Single Institution Experience.
-
Hematopoietic Stem Cell Transplantation in ADA2 Deficiency: Early Restoration of ADA2 Enzyme Activity and Disease Relapse upon Drop of Donor Chimerism.
-
Hematopoietic cell infusion for the treatment of nuclear disaster victims: new data from the Chernobyl accident.
-
Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma.
-
Hematopoietic cell transplantation for Chediak-Higashi syndrome.
-
Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States.
-
Hematopoietic chimerism achieved by in utero hematopoietic stem cell injection does not induce donor-specific tolerance for renal allografts in sheep.
-
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.
-
Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling.
-
Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation.
-
Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey.
-
Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2.
-
Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.
-
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.
-
Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
-
Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy.
-
Hematopoietic stem-cell transplantation.
-
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type.
-
Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.
-
Hepatocellular adenoma among adult survivors of childhood and young adult cancer.
-
High Variability in the Reported Management of Hepatic Veno-Occlusive Disease in Children after Hematopoietic Stem Cell Transplantation.
-
High dose chemotherapy with autologous peripheral blood progenitor cell transplantation in an anephric child with multiply recurrent Wilms tumor.
-
High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma.
-
High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.
-
High-Frequency Oscillatory Ventilation Use and Severe Pediatric ARDS in the Pediatric Hematopoietic Cell Transplant Recipient.
-
High-dose 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase I trial.
-
High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma.
-
High-dose chemotherapy with AHPCS for the treatment of breast cancer. The University of Colorado results.
-
High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes.
-
High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.
-
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.
-
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.
-
High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes.
-
High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-cell transplantation in patients with refractory lymphoid malignancies.
-
High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.
-
High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy.
-
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
-
Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms.
-
Holding back moderates the association between health symptoms and social well-being in patients undergoing hematopoietic stem cell transplantation.
-
How I treat ADA deficiency.
-
How I treat sinusoidal obstruction syndrome.
-
Human fetal liver hematopoietic cell expansion with a novel bioreactor system.
-
Human herpesvirus 6 limbic encephalitis after stem cell transplantation.
-
Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research.
-
Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells.
-
Hyper IgM Syndrome: a Report from the USIDNET Registry.
-
Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.
-
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.
-
Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.
-
Immune therapies for neuroblastoma.
-
Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.
-
Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support.
-
Impact of continuous renal replacement therapy on oxygenation in children with acute lung injury after allogeneic hematopoietic stem cell transplantation.
-
Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
-
Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma.
-
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
-
Improvements in digital vasculature observed using micro magnetic resonance angiography after high-dose immunosuppression for severe systemic sclerosis.
-
Improving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.
-
Improving the outcome of umbilical cord blood transplantation through ex vivo expansion or graft manipulation.
-
In reply.
-
In utero hematopoietic stem cell transplants prolong survival of postnatal kidney transplantation in monkeys.
-
In utero transplantation of rat hematopoietic stem cells induces xenogeneic chimerism in mice.
-
In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial.
-
In vivo engineering of bone tissues with hematopoietic functions and mixed chimerism.
-
In vivo models of human lymphopoiesis and autoimmunity in severe combined immune deficient mice.
-
Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone.
-
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation.
-
Increasing Nocardia Incidence Associated with Bronchiectasis at a Tertiary Care Center.
-
Increasing chimerism after allogeneic stem cell transplantation is associated with longer survival time.
-
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
-
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.
-
Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.
-
Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies.
-
Induction of type I IFN is required for overcoming tumor-specific T-cell tolerance after stem cell transplantation.
-
Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy.
-
Infections diagnosed in the first year after pediatric stem cell transplantation.
-
Influence of preparatory regimen and source of hematopoietic cells on outcome of autotransplantation for non-Hodgkin's lymphoma.
-
Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation.
-
Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.
-
Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal.
-
Innate immune activation by the viral PAMP poly I:C potentiates pulmonary graft-versus-host disease after allogeneic hematopoietic cell transplant.
-
Innate immune activation potentiates alloimmune lung disease independent of chemokine (C-X-C motif) receptor 3.
-
Intensive care unit experience of haemopoietic stem cell transplant patients.
-
Intensive chemotherapy for progressive chronic lymphocytic leukemia administered early after a nonmyeloablative allograft.
-
International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I).
-
International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma.
-
Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.
-
Intramyocardial, autologous CD34+ cell therapy for refractory angina.
-
Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
-
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.
-
Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit.
-
Intravenous busulfan plus melphalan is a highly effective, well-tolerated preparative regimen for autologous stem cell transplantation in patients with advanced lymphoid malignancies.
-
Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality.
-
Invasive Mechanical Ventilation and Mortality in Pediatric Hematopoietic Stem Cell Transplantation: A Multicenter Study.
-
Iron overload and allogeneic hematopoietic stem-cell transplantation.
-
Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation.
-
Is timing everything?
-
Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.
-
Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.
-
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study.
-
Krabbe disease treated with hematopoietic stem cell transplantation: serial assessment of anisotropy measurements--initial experience.
-
Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation.
-
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.
-
Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors.
-
Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells.
-
Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes.
-
Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS).
-
Long-term in vivo imaging of multiple organs at the single cell level.
-
Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study.
-
Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.
-
Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep.
-
Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism.
-
Longterm followup and quality of life after hematopoietic stem cell transplantation.
-
Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.
-
Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism.
-
MR and proton spectroscopy of white matter disease induced by high-dose chemotherapy with bone marrow transplant in advanced breast carcinoma.
-
Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.
-
Management of invasive mycoses in hematology patients: current approaches.
-
Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.
-
Memory T cells: A helpful guard for allogeneic hematopoietic stem cell transplantation without causing graft-versus-host disease.
-
Mini test dose of intravenous busulfan (busulfex(®)) in allogeneic non-myeloablative stem cell transplantation, followed by liquid chromatography tandem-mass spectrometry.
-
Mobilization, collection, and processing of autologous peripheral blood stem cells: development of a clinical process with associated costs.
-
Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics.
-
Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells.
-
Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras.
-
Molecular profile and partial functional analysis of novel endothelial cell-derived growth factors that regulate hematopoiesis.
-
Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies.
-
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
-
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.
-
Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation.
-
Myelodysplastic syndromes clinical practice guidelines in oncology.
-
Myelodysplastic syndromes in the United States: an update for clinicians.
-
Myelodysplastic syndromes: clinical practice guidelines in oncology.
-
Myeloid growth factors.
-
NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia.
-
NCCN clinical practice guidelines in oncology: multiple myeloma.
-
NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions.
-
National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines.
-
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.
-
National estimates of the use of hematopoietic stem-cell transplantation in children with cancer in the United States.
-
Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation.
-
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.
-
Neonatal W-mutant mice are favorable hosts for tracking development of marked hematopoietic stem cells.
-
Newborn screening for Krabbe disease in New York State: the first eight years' experience.
-
Newborn screening for Krabbe disease: the New York State model.
-
Nocardia infections in the transplanted host.
-
Non-Aspergillus fungal pneumonia in transplant recipients.
-
Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
-
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia.
-
Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
-
Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal Model.
-
Ocular toxicity following high dose chemotherapy and autologous transplant.
-
Older patients with myeloma derive similar benefit from autologous transplantation.
-
Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support.
-
Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality.
-
Organ transplantation in HIV-infected patients.
-
Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy-related acute myeloid leukemia or myelodysplastic syndrome.
-
Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome.
-
Outcome of transplantation for acute myelogenous leukemia in children with Down syndrome.
-
Outcomes after hematopoietic stem cell transplantation for children with I-cell disease.
-
Outcomes among 562 recipients of placental-blood transplants from unrelated donors.
-
Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation.
-
Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning.
-
Outcomes of 122 diverse adult and pediatric cord blood transplant recipients from a large cord blood bank.
-
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.
-
Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma.
-
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.
-
Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection.
-
Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation.
-
Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.
-
Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.
-
Outcomes of hematopoietic stem cell transplant patients who received continuous renal replacement therapy in a pediatric oncology intensive care unit.
-
Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia.
-
Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.
-
Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning.
-
Overview of electronic data sharing: why, how, and impact.
-
PD-L1 serves as a double agent in separating GVL from GVHD.
-
Pain Syndromes and Management in Adult Hematopoietic Stem Cell Transplantation.
-
Partial splenectomy before a hematopoietic stem cell transplantation in children.
-
Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.
-
Patient perspectives on physical function after allogeneic hematopoietic stem cell transplantation: a qualitative study.
-
Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications.
-
Payment and Care for Hematopoietic Cell Transplantation Patients: Toward a Specialized Medical Home for Complex Care Patients.
-
Pediatric Acute Respiratory Distress Syndrome in Pediatric Allogeneic Hematopoietic Stem Cell Transplants: A Multicenter Study.
-
Pediatric hematopoietic stem cell transplantation and the role of imaging.
-
Pericarditis mediated by respiratory syncytial virus in a hematopoietic stem cell transplant patient.
-
Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
-
Peripheral blood stem cell transplantation in breast cancer.
-
Peripheral blood stem cells for autografting.
-
Peripheral neuropathy in Krabbe disease: effect of hematopoietic stem cell transplantation.
-
Peripheral neuropathy in Krabbe disease: electrodiagnostic findings.
-
Personalized home-based interval exercise training may improve cardiorespiratory fitness in cancer patients preparing to undergo hematopoietic cell transplantation.
-
Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients.
-
Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.
-
Phase I/II Trial of Dose-Escalated Busulfan Delivered by Prolonged Continuous Infusion in Allogeneic Transplant Patients.
-
Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.
-
Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.
-
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
-
Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease.
-
Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients.
-
Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.
-
Plasma microRNA-586 is a new biomarker for acute graft-versus-host disease.
-
Pleiotrophin regulates the retention and self-renewal of hematopoietic stem cells in the bone marrow vascular niche.
-
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
-
Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report.
-
Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.
-
Polyclonal long-term MFGS-gp91phox marking in rhesus macaques after nonmyeloablative transplantation with transduced autologous peripheral blood progenitor cells.
-
Polymyositis as a manifestation of chronic graft-versus-host disease.
-
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients.
-
Positive selection of CD34+ hematopoietic progenitor cells for transplantation.
-
Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.
-
Post-mortem incidental finding of cytomegalovirus oophoritis after an allogeneic stem cell transplant.
-
Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.
-
Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation.
-
Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients.
-
Pretransplantation Supportive and Palliative Care Consultation for High-Risk Hematopoietic Cell Transplantation Patients.
-
Pretransplantation assessments and symptom profiles: predicting transplantation-related toxicity and improving patient-centered outcomes.
-
Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond.
-
Preventing stem cell incorporation into choroidal neovascularization by targeting homing and attachment factors.
-
Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
-
Prevention of GVHD without losing GVL effect: windows of opportunity.
-
Prognostic analysis of early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplant.
-
Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.
-
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis.
-
Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer.
-
Prognostic significance of occult tumor cells in the apheresis products of patients with advanced breast cancer receiving high-dose chemotherapy and autologous hematopoietic progenitor cell support.
-
Progress in graft-versus-host disease.
-
Prophylaxis and treatment of acute graft-versus-host disease.
-
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study.
-
Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients.
-
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
-
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.
-
Protective role of T-bet and Th1 cytokines in pulmonary graft-versus-host disease and peribronchiolar fibrosis.
-
Protein tyrosine phosphatase-σ regulates hematopoietic stem cell-repopulating capacity.
-
Providing personalized prognostic information for adult leukemia survivors.
-
Pseudo-Pelger-Huët anomaly induced by transplant medications.
-
Pulmonary sarcoidosis following stem cell transplantation: is it more than a chance occurrence?
-
Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.
-
Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia.
-
Quantitative measures of physical functioning after autologous hematopoietic stem cell transplantation in multiple myeloma: a feasibility study.
-
Randomized clinical trial of therapeutic music video intervention for resilience outcomes in adolescents/young adults undergoing hematopoietic stem cell transplant: a report from the Children's Oncology Group.
-
Randomized clinical trials for hematopoietic stem cell transplantation: lessons to be learned from the European experience.
-
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.
-
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
-
Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
-
Recent developments in the treatment of older individuals with acute myeloid leukemia: 2014.
-
Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
-
Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.
-
Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants.
-
Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor.
-
Reduced-intensity allogeneic transplantation provides high event-free and overall survival in patients with advanced indolent B cell malignancies: CALGB 109901.
-
Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies.
-
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for patients with hematologic malignancies who relapse following autologous transplantation: a multi-institutional prospective study from the Cancer and Leukemia Group B (CALGB trial 100002).
-
Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT.
-
Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.
-
Release of tumor cells from bone marrow.
-
Renal dysfunction in allogeneic hematopoietic cell transplantation.
-
Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trial.
-
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML).
-
Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors.
-
Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations.
-
Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary Involvement.
-
Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review.
-
Risk factors for acute GVHD and survival after hematopoietic cell transplantation.
-
Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.
-
Role of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations.
-
Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.
-
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation.
-
Safety of growth factor administration for leukapheresis in those with WBC counts greater than 60,000/µl.
-
Salvage therapy in Hodgkin's lymphoma.
-
Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.
-
Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure.
-
Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
-
Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation.
-
Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma.
-
Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells.
-
Shared Decision-Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease.
-
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.
-
Sources of human and murine hematopoietic stem cells.
-
State of the art in umbilical cord transplantation.
-
Status of high-dose chemotherapy for breast cancer: a review.
-
Stem cell isolation.
-
Stem cell source and outcome after hematopoietic stem cell transplantation (HSCT) in children and adolescents with acute leukemia.
-
Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts.
-
Stem cell use in a patient with an ischemic foot ulcer: a case study.
-
Stem-cell transplantation for chronic granulomatous disease.
-
Stem-cell transplantation for inherited immunodeficiency disorders.
-
Stem-cell transplantation for the treatment of advanced solid tumors.
-
Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen.
-
Successful treatment of disseminated BCG in a patient with severe combined immunodeficiency.
-
Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny.
-
Symptom prevalence and physiologic biomarkers among adolescents using a mobile phone intervention following hematopoietic stem cell transplantation.
-
Symptomatic BK Virus Infection Is Associated With Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients.
-
Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues.
-
T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates.
-
T-Cell recovery in adults and children following umbilical cord blood transplantation.
-
Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.
-
Technology evaluation: Stem-cell therapy, Aastrom Biosciences Inc.
-
The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation.
-
The Diagnostic Yield of Site and Symptom-Based Biopsies for Acute Gastrointestinal Graft-Versus-Host Disease: A 5-Year Retrospective Review.
-
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.
-
The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques.
-
The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia.
-
The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.
-
The biology and ethics of banking fetal liver hematopoietic stem cells for in utero transplantation.
-
The critical role of hematopoietic cells in lipopolysaccharide-induced airway inflammation.
-
The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).
-
The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation.
-
The evolution of the evidence-based review: evaluating the science enhances the art of medicine--statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation.
-
The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases.
-
The long quest for neonatal screening for severe combined immunodeficiency.
-
The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901.
-
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission.
-
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
-
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review.
-
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review.
-
The significance of microbial cultures of the hematopoietic support for patients receiving high-dose chemotherapy.
-
The use of high-dose cyclophosphamide, carmustine, and thiotepa plus autologous hematopoietic stem cell transplantation as consolidation therapy for high-risk primary breast cancer after primary surgery or neoadjuvant chemotherapy.
-
The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation.
-
Therapy of inflammatory bowel disease: what to expect in the next decade.
-
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.
-
Thrombocytopenia in allogeneic peripheral blood stem cell collections.
-
Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
-
Thymic hyperplasia after high-dose chemotherapy and autologous stem cell transplantation: incidence and significance in patients with breast cancer.
-
Tie2(+) bone marrow endothelial cells regulate hematopoietic stem cell regeneration following radiation injury.
-
Topical lineage-negative progenitor-cell therapy for diabetic wounds.
-
Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease.
-
Transplant outcomes in mucopolysaccharidoses.
-
Transplantation and aging.
-
Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants.
-
Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.
-
Transplantation of CD34+ hematopoietic progenitor cells.
-
Transplantation of cord-blood cells.
-
Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.
-
Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma.
-
Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.
-
Transplantation outcomes for severe combined immunodeficiency, 2000-2009.
-
Treatment of Inherited Eye Defects by Systemic Hematopoietic Stem Cell Transplantation.
-
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
-
Treatment of infants with complete DiGeorge anomaly.
-
Treatment of non-Hodgkin's lymphoma with high-dose therapy and hematopoietic stem cell support.
-
Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT).
-
Treatment options for genetically determined immunodeficiency.
-
Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cells.
-
Umbilical cord blood hematopoietic stem and repopulating cells in human clinical transplantation.
-
Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies.
-
Umbilical cord blood: a novel alternative source of hematopoietic stem cells for bone marrow transplantation.
-
Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial.
-
Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.
-
Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry.
-
Unrelated placental blood in marrow transplantation.
-
Unrelated umbilical cord blood stem cell transplant after failure of haploidentical or matched unrelated donor hematopoietic stem cell transplant.
-
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial.
-
Use of external ventriculostomy and intrathecal anti-fungal treatment in cerebral mucormycotic abscess.
-
Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation.
-
VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression.
-
Value of surgical resection in children with high-risk neuroblastoma.
-
Vascular endothelial cells produce soluble factors that mediate the recovery of human hematopoietic stem cells after radiation injury.
-
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
-
White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy.
-
gammadelta T cells: a new frontier for immunotherapy?
-
Keywords of People
-
Barfield, Raymond Carlton,
Professor of Pediatrics,
Duke Science & Society
-
Buckley, Rebecca Hatcher,
James Buren Sidbury Professor of Pediatrics, in the School of Medicine,
Immunology
-
Chen, Jun,
Associate Professor of Medicine,
Duke Cancer Institute
-
Gunn, Michael Dee,
Professor of Medicine,
Immunology
-
Pitt, Geoffrey Stuart,
Adjunct Professor in the Department of Medicine,
Medicine, Cardiology
-
Tsalik, Ephraim,
Associate Professor of Medicine,
Molecular Genetics and Microbiology
-
Yang, Yiping,
Professor of Medicine,
Immunology